Meloxicam and Sinus node dysfunction - a phase IV clinical study of FDA data

Summary:

Sinus node dysfunction is reported as a side effect among people who take Meloxicam (meloxicam), especially for people who are male, 50-59 old, also take Spiriva, and have Narcolepsy.

The phase IV clinical study analyzes which people have Sinus node dysfunction when taking Meloxicam. It is created by eHealthMe based on reports of 64,757 people who have side effects when taking Meloxicam from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 67,998 Meloxicam users. Check the latest studies of Meloxicam.

What is Sinus node dysfunction?

Sinus node dysfunction (a group of abnormal heart rhythms) is found to be associated with 1,222 drugs and 837 conditions by eHealthMe. Check the latest studies of Sinus node dysfunction.

On Oct, 26, 2025

64,757 people reported to have side effects when taking Meloxicam.
Among them, 19 people (0.03%) have Sinus node dysfunction.

Could Meloxicam cause Sinus node dysfunction?

Among these 19 people:

What is the gender of people who have Sinus node dysfunction when taking Meloxicam? *

female: 50 %
male: 50 %

What is the age of people who have Sinus node dysfunction when taking Meloxicam? *

What are other drugs people take besides Meloxicam? *

What are other side effects people have besides Sinus node dysfunction? *

Depression: 9 people, 47.37%
Weakness: 9 people, 47.37%
Oedema Peripheral (superficial swelling): 7 people, 36.84%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 36.84%
Weight Decreased: 6 people, 31.58%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 6 people, 31.58%
Cardiac Murmur (an heart sound in valve abnormality): 6 people, 31.58%
Cardiac Failure Congestive: 6 people, 31.58%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 31.58%
Anaemia (lack of blood): 6 people, 31.58%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 36.84%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 31.58%
Cardiac Failure Congestive: 5 people, 26.32%
Osteoporosis (bones weak and more likely to break): 3 people, 15.79%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 10.53%
Drowsiness: 2 people, 10.53%
Heart Rate Increased: 1 person, 5.26%
Breakthrough Pain: 1 person, 5.26%
Cough: 1 person, 5.26%
Dyspnea (difficult or laboured breathing): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and have Sinus node dysfunction?

- Check whether Sinus node dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meloxicam:

Meloxicam (67,998 reports)

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus node dysfunction:

Sinus node dysfunction (1,222 drugs)

Browse all the conditions that are associated with Sinus node dysfunction:

Sinus node dysfunction (837 conditions)

Drugs similar to Meloxicam and Sinus node dysfunction :

Related publications that referenced our studies

Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam (the active ingredients of Meloxicam) and Meloxicam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.